ReviewThe Journal of clinical investigation2002
Cancer vaccines: progress reveals new complexities.
Review in The Journal of clinical investigation, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The Efficacy of Neoantigen-Loaded Dendritic Cell Vaccine Immunotherapy in Non-Metastatic Gastric Cancer.Medical sciences (Basel, Switzerland) · 2025Pooled it
- Induction of cellular immune responses against carcinoembryonic antigen in patients with metastatic tumors after vaccination with altered peptide ligand-loaded dendritic cells.Cancer immunology, immunotherapy : CII · 2006Trial
- Immune response induced in vitro by CD16- and CD16+ monocyte-derived dendritic cells in patients with metastatic renal cell carcinoma treated with dendritic cell vaccines.Journal of clinical immunology · 2004Trial
- Advances and key focus areas in gastric cancer immunotherapy: A comprehensive scientometric and clinical trial review (1999-2023).World journal of gastroenterology · 2023Review
- Potential association factors for developing effective peptide-based cancer vaccines.Frontiers in immunology · 2022Article
- Immunotherapeutic Targeting of Tumor-Associated Blood Vessels.Advances in experimental medicine and biology · 2017Review
- Dendritic cells based immunotherapy.American journal of cancer research · 2017Review
- Vaccines targeting tumor blood vessel antigens promote CD8(+) T cell-dependent tumor eradication or dormancy in HLA-A2 transgenic mice.Journal of immunology (Baltimore, Md. : 1950) · 2012Article
- Intratumoral IL-12 gene therapy results in the crosspriming of Tc1 cells reactive against tumor-associated stromal antigens.Molecular therapy : the journal of the American Society of Gene Therapy · 2011Article
- From tumor immunosuppression to eradication: targeting homing and activity of immune effector cells to tumors.Clinical & developmental immunology · 2011Review
- Increased intensity lymphodepletion enhances tumor treatment efficacy of adoptively transferred tumor-specific T cells.Journal of immunotherapy (Hagerstown, Md. : 1997) · 2010Article
- Immunotherapy of malignant disease with tumor antigen-specific monoclonal antibodies.Clinical cancer research : an official journal of the American Association for Cancer Research · 2010Review
- Human suppressor of cytokine signaling 1 controls immunostimulatory activity of monocyte-derived dendritic cells.Cancer research · 2009Article
- Tumour antigen-targeted immunotherapy for chronic myeloid leukaemia: is it still viable?Cancer immunology, immunotherapy : CII · 2009Review
- Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma.Cancer immunity · 2009Review
- Interactions of host IL-6 and IFN-gamma and cancer-derived TGF-beta1 on MHC molecule expression during tumor spontaneous regression.Cancer immunology, immunotherapy : CII · 2008Article
- Autoantibodies to tumor-associated antigens: reporters from the immune system.Immunological reviews · 2008Review
- De novo induction of a cancer/testis antigen by 5-aza-2'-deoxycytidine augments adoptive immunotherapy in a murine tumor model.Cancer research · 2006Article
- Combining radiotherapy and immunotherapy: a revived partnership.International journal of radiation oncology, biology, physics · 2005Review
- The Silver locus product Pmel17/gp100/Silv/ME20: controversial in name and in function.Pigment cell research · 2005Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.